Effects of COVID-19 on short-term outcomes of hip arthroplasty: a multicenter, retrospective, propensity score

Shih-Hui Peng1,2, Yu-Chih Lin1,3, Chih-Hsiang Chang1,4

  • 1Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.

PubMed

Insights

COVID-19 infection increased the risk of postoperative pneumonia and urinary tract infections following hip arthroplasty. While not significantly raising the risk of periprosthetic joint infection, it complicated treatment due to culture-negativity.

Area of Science:

  • Orthopedic surgery
  • Infectious disease epidemiology
  • Public health

Background:

  • The COVID-19 pandemic disrupted elective surgical procedures, including hip arthroplasty.
  • Understanding the impact of COVID-19 on surgical outcomes is crucial as procedures resume.
  • Short-term outcomes after hip arthroplasty in the context of COVID-19 require investigation.

Purpose of the Study:

  • To explore the effects of a prior COVID-19 infection on short-term outcomes after hip arthroplasty.
  • To compare complication rates between hip arthroplasty patients with and without a history of COVID-19.
  • To identify specific risks associated with COVID-19 in the perioperative period of hip replacement.

Main Methods:

  • Multicenter, retrospective, case-control study design.
  • Inclusion of hip arthroplasty patients from 2020-2022.
  • Propensity score matching (PSM) to compare COVID-19 cohort (n=153) with a control cohort (n=4925).
  • Assessment of primary outcomes (e.g., surgical site infection, PJI, PE) and secondary outcomes (e.g., pneumonia, UTI).

Main Results:

  • Significant increases in postoperative pneumonia and urinary tract infection (UTI) rates were observed in the COVID-19 cohort post-PSM.
  • The odds ratio for periprosthetic joint infection (PJI) was 1.62, but this finding was not statistically significant (p=0.3238).
  • A higher rate of culture-negativity was noted in PJI cases within the COVID-19 cohort (25%).

Conclusions:

  • COVID-19 infection is associated with elevated risks of postoperative pneumonia and UTI after hip arthroplasty.
  • The study did not find a significant increase in 90-day mortality or major perioperative complications directly linked to COVID-19.
  • Periprosthetic joint infection (PJI) remains a concern due to challenging treatment, often exacerbated by culture-negativity, potentially leading to Girdlestone procedures.
Abstract

Related Concept Videos